Shringarpure Reshma, Grune Tilman, Mehlhase Jana, Davies Kelvin J A
Ethel Percy Andrus Gerontology Center and Division of Molecular and Computational Biology, University of Southern California, Los Angeles, California 90089-0191, USA.
J Biol Chem. 2003 Jan 3;278(1):311-8. doi: 10.1074/jbc.M206279200. Epub 2002 Oct 24.
Oxidatively modified proteins that accumulate in aging and many diseases can form large aggregates because of covalent cross-linking or increased surface hydrophobicity. Unless repaired or removed from cells, these oxidized proteins are often toxic, and threaten cell viability. Most oxidatively damaged proteins appear to undergo selective proteolysis, primarily by the proteasome. Previous work from our laboratory has shown that purified 20 S proteasome degrades oxidized proteins without ATP or ubiquitin in vitro, but there have been no studies to test this mechanism in vivo. The aim of this study was to determine whether ubiquitin conjugation is necessary for the degradation of oxidized proteins in intact cells. We now show that cells with compromised ubiquitin-conjugating activity still preferentially degrade oxidized intracellular proteins, at near normal rates, and this degradation is still inhibited by proteasome inhibitors. We also show that progressive oxidation of proteins such as lysozyme and ferritin does not increase their ubiquitinylation, yet the oxidized forms of both proteins are preferentially degraded by proteasome. Furthermore, rates of oxidized protein degradation by cell lysates are not significantly altered by addition of ATP, excluding the possibility of an energy requirement for this pathway. Contrary to earlier popular belief that most proteasomal degradation is conducted by the 26 S proteasome with ubiquitinylated substrates, our work suggests that oxidized proteins are degraded without ubiquitin conjugation (or ATP hydrolysis) possibly by the 20 S proteasome, or the immunoproteasome, or both.
在衰老及多种疾病过程中积累的氧化修饰蛋白,由于共价交联或表面疏水性增加,会形成大的聚集体。除非从细胞中修复或清除,这些氧化蛋白通常具有毒性,并威胁细胞的生存能力。大多数氧化损伤的蛋白似乎主要通过蛋白酶体进行选择性蛋白水解。我们实验室之前的工作表明,纯化的20S蛋白酶体在体外无需ATP或泛素就能降解氧化蛋白,但尚未有研究在体内测试这一机制。本研究的目的是确定泛素缀合对于完整细胞中氧化蛋白的降解是否必要。我们现在表明,泛素缀合活性受损的细胞仍然以接近正常的速率优先降解细胞内氧化蛋白,并且这种降解仍然受到蛋白酶体抑制剂的抑制。我们还表明,诸如溶菌酶和铁蛋白等蛋白的渐进氧化不会增加它们的泛素化,但这两种蛋白的氧化形式都被蛋白酶体优先降解。此外,添加ATP不会显著改变细胞裂解物对氧化蛋白的降解速率,排除了该途径需要能量的可能性。与早期普遍认为的大多数蛋白酶体降解是由带有泛素化底物的26S蛋白酶体进行的观点相反,我们的工作表明,氧化蛋白可能通过20S蛋白酶体或免疫蛋白酶体或两者在没有泛素缀合(或ATP水解)的情况下被降解。